EUVIMEDEUVIMED entdecken
Übersichtsarbeit

International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention

Dominick J Angiolillo, Mattia Galli, Dimitrios Alexopoulos, Daniel Aradi, Deepak L Bhatt, Laurent Bonello, Davide Capodanno, Larisa H Cavallari, Jean-Philippe Collet, Thomas Cuisset, Jose Luis Ferreiro, Francesco Franchi und 21 weitere

JACC: Cardiovascular Interventions · 2024-11 · 17 (22) · 2639-2663

DOI: 10.1016/j.jcin.2024.08.027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2024-11. Verfasst von Dominick J Angiolillo und 32 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA. Electronic address: dominick.angiolillo@jax.ufl.edu. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Platelet Function Tests, Hemorrhage. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 168 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current evidence indicates that dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor is essential for the prevention of thrombotic events after percutaneous coronary interventions. However, dual antiplatelet therapy is associated with increased bleeding which may outweigh the benefits. This has set the foundations for customizing antiplatelet treatments to the individual patient. However, bleeding and ischemic risks are often present in the same patient, making it difficult to achieve this balance. The fact that oral P2Y12 inhibitors (clopidogrel, prasugrel, and ticagrelor) have diverse pharmacodynamic profiles that affect clinical outcomes supports the rationale for using platelet function and genetic testing to individualize antiplatelet treatment regimens. Indeed, up to one-third of patients treated with clopidogrel, but a minority of those treated with prasugrel or ticagrelor, exhibit high residual platelet reactivity resulting in an increased thrombotic risk. On the other hand, prasugrel and ticagrelor are frequently associated with low platelet reactivity and increased bleeding risk compared with clopidogrel without providing any additional reduction in ischemic events compared with patients who adequately respond to clopidogrel. The use of platelet function and genetic testing may allow for a guided selection of oral P2Y12 inhibitors. However, the nonuniform results of randomized controlled trials have led guidelines to provide limited recommendations on the implementation of these tests in patients undergoing percutaneous coronary intervention. In light of recent advancements in the field, this consensus document by a panel of international experts fills in the guideline gap by providing updates on the latest evidence in the field as well as recommendations for clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionPlatelet Aggregation InhibitorsPlatelet Function TestsHemorrhagePurinergic P2Y Receptor AntagonistsClinical Decision-MakingPredictive Value of TestsBlood PlateletsHumansRisk FactorsRisk AssessmentTreatment OutcomePharmacogenomic VariantsDual Anti-Platelet TherapyPharmacogenomic TestingPrecision MedicinePatient SelectionCoronary ThrombosisCoronary Artery DiseasePhenotypeGenetic Testing

Stichwörter der Autor:innen

P2Y(12) inhibitorgenetic testingguided antiplatelet therapypercutaneous coronary interventionplatelet function testingprecision medicine

Substanzen

Platelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonists

Autor:innen und Institutionen

  • Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA. Electronic address: dominick.angiolillo@jax.ufl.edu.
  • Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
  • 7th Department of Cardiology, Hygeia Hospital, Athens, Greece; State Hospital for Cardiology, Balatonfüred, Hungary.
  • State Hospital for Cardiology, Balatonfüred, Hungary; Hungary and Heart and Vascular Centre, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Intensive Care Unit, Hopital Universitaire Nord, Aix-Marseille University, Marseille, France.

Zitieren

APA

Angiolillo, D. J., Galli, M., Alexopoulos, D., Aradi, D., Bhatt, D. L., Bonello, L., Capodanno, D., Cavallari, L. H., Collet, J. P., Cuisset, T., Ferreiro, J. L., Franchi, F., Geisler, T., Gibson, C. M., Gorog, D. A., Gurbel, P. A., Jeong, Y. H., Marcucci, R., Siller-Matula, J. M., …, & Sibbing, D. (2024). International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 17(22), 2639-2663. https://doi.org/10.1016/j.jcin.2024.08.027

Vancouver

Angiolillo DJ, Galli M, Alexopoulos D, Aradi D, Bhatt DL, Bonello L, et al. International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 2024;17(22):2639-2663. doi:10.1016/j.jcin.2024.08.027

BibTeX
@article{Angiolillo2024,
  author = {Angiolillo, Dominick J and Galli, Mattia and Alexopoulos, Dimitrios and Aradi, Daniel and Bhatt, Deepak L and Bonello, Laurent and Capodanno, Davide and Cavallari, Larisa H and Collet, Jean-Philippe and Cuisset, Thomas and Ferreiro, Jose Luis and Franchi, Francesco and Geisler, Tobias and Gibson, C Michael and Gorog, Diana A and Gurbel, Paul A and Jeong, Young-Hoon and Marcucci, Rossella and Siller-Matula, Jolanta M and Mehran, Roxana and Neumann, Franz-Josef and Pereira, Naveen L and Rizas, Konstantinos D and Rollini, Fabiana and So, Derek Y F and Stone, Gregg W and Storey, Robert F and Tantry, Udaya S and Berg, Jurrien Ten and Trenk, Dietmar and Valgimigli, Marco and Waksman, Ron and Sibbing, Dirk},
  title = {International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention},
  journal = {JACC: Cardiovascular Interventions},
  year = {2024},
  volume = {17},
  number = {22},
  pages = {2639--2663},
  doi = {10.1016/j.jcin.2024.08.027}
}
Kostenlos starten →